Radiological assessment of mandibular invasion in squamous cell carcinoma of the oral cavity and oropharynx.


Journal

European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 15 6 2019
medline: 18 3 2020
entrez: 15 6 2019
Statut: ppublish

Résumé

Preoperative assessment of mandibular bone invasion in squamous cell carcinoma of the oral cavity and oropharynx is crucial for optimizing bone resection. The principal aim of this study was to evaluate the diagnostic value of CT and MR imaging for the diagnosis of mandibular bone invasion compared to the histological reference. In addition, we assessed the survival impact of bone invasion. A single-center retrospective study included all consecutive patients treated by mandibular bone interruption for squamous cell carcinoma of the oral cavity and/or oropharynx. Sixty-eight patients were included. Prevalence of bone invasion on histology was 43%. Sensitivity, specificity and positive and negative predictive value were respectively 70%, 71%, 66% and 76% for CT compared with histologic analysis, 83%, 50%, 59% and 78% for MRI, and 83%, 62% 62%, 83% for associated CT and MRI. The two tests showed good agreement, with kappa index 0.69 (95% CI, 0.49-0.89) (P<0.0001). There was no difference in overall survival (log-rank>0.70) between the groups with and without bone invasion. CT and MRI are complementary for preoperative assessment of mandibular bone invasion, be it cortical and/or medullary, and in some cases may allow mandibular bone-sparing.

Sections du résumé

BACKGROUND BACKGROUND
Preoperative assessment of mandibular bone invasion in squamous cell carcinoma of the oral cavity and oropharynx is crucial for optimizing bone resection. The principal aim of this study was to evaluate the diagnostic value of CT and MR imaging for the diagnosis of mandibular bone invasion compared to the histological reference. In addition, we assessed the survival impact of bone invasion.
PATIENTS AND METHODS METHODS
A single-center retrospective study included all consecutive patients treated by mandibular bone interruption for squamous cell carcinoma of the oral cavity and/or oropharynx.
RESULTS RESULTS
Sixty-eight patients were included. Prevalence of bone invasion on histology was 43%. Sensitivity, specificity and positive and negative predictive value were respectively 70%, 71%, 66% and 76% for CT compared with histologic analysis, 83%, 50%, 59% and 78% for MRI, and 83%, 62% 62%, 83% for associated CT and MRI. The two tests showed good agreement, with kappa index 0.69 (95% CI, 0.49-0.89) (P<0.0001). There was no difference in overall survival (log-rank>0.70) between the groups with and without bone invasion.
CONCLUSION CONCLUSIONS
CT and MRI are complementary for preoperative assessment of mandibular bone invasion, be it cortical and/or medullary, and in some cases may allow mandibular bone-sparing.

Identifiants

pubmed: 31196801
pii: S1879-7296(19)30095-X
doi: 10.1016/j.anorl.2019.05.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

361-366

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

S Bouhir (S)

Service d'ORL et de chirurgie cervico-faciale, CHU de Lille, université de Lille, hôpital Huriez, rue Michel-Polonovski, 59037 Lille, France.

G Mortuaire (G)

Service d'ORL et de chirurgie cervico-faciale, CHU de Lille, université de Lille, hôpital Huriez, rue Michel-Polonovski, 59037 Lille, France.

F Dubrulle-Berthelot (F)

Service de radiologie et imagerie interventionnelle, CHU de Lille, université de Lille, hôpital Huriez, rue Michel-Polonovski, 59037 Lille, France.

X Leroy (X)

Service d'anatomo-pathologie, centre de biologie pathologie, CHU de Lille, université de Lille, boulevard du Professeur Jules-Leclercq, 59037 Lille, France.

V Deken-Delannoy (V)

Unité de méthodologie, biostatistique et data management, maison régionale de la recherche clinique, CHU de Lille, rue du Professeur Laguesse, 59037 Lille, France.

B Rysman (B)

Service d'ORL et de chirurgie cervico-faciale, CHU de Lille, université de Lille, hôpital Huriez, rue Michel-Polonovski, 59037 Lille, France.

D Chevalier (D)

Service d'ORL et de chirurgie cervico-faciale, CHU de Lille, université de Lille, hôpital Huriez, rue Michel-Polonovski, 59037 Lille, France.

F Mouawad (F)

Service d'ORL et de chirurgie cervico-faciale, CHU de Lille, université de Lille, hôpital Huriez, rue Michel-Polonovski, 59037 Lille, France; Inserm U 908, UFR de biologie, SN3, université des sciences et technologies de Lille, 59655 Villeneuve d'Ascq, France. Electronic address: francois.mouawad@chru-lille.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH